For the second consecutive year, SCOR is named “North American Reinsurer of the Year” at the Reactions Magazine North America awards.
For the second consecutive year, SCOR is named “North American Reinsurer of the Year” at the Reactions Magazine North America awards.
This award attributed to SCOR for the second year in succession confirms the Group’s reinforced leadership in the US individual Life market.
This award attributed to SCOR for the second year in succession confirms the Group’s reinforced leadership in the US individual Life market.
October 5, 2016
"Should we fear pandemics?” Lecture by Arnaud Fontanet SCOR Paris auditorium, 5 October 2016
At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
German version - At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
August 30, 2016
Alexander Fleming’s discovery of Penicillin in 1928 marked one of the proudest achievements of 20th Century medicine. A decade of R&D later and suddenly mankind had the ability to fight a whole class of diseases.
Half-year 2016 results.
The interim financial report for the six months ended 30 June 2016 is available on the company's website at www.scor.com.
Billions of pounds is spent on research on cancer, and survival statistics continue to improve year on year. New treatment methods continue to be developed.
Billions of pounds is spent on research on cancer, and survival statistics continue to improve year on year. New treatment methods continue to be developed.
Pagination